Stada Takes ViruProtect To Russia And Beyond
Germany's Stada has expanded its deal with Enymatica to take the latter's ViruProtect common cold brand into Russia, the CIS and beyond.
You may also be interested in...
Stada to launch innovative common cold spray ViruProtect in four Nordic markets in 2021 after striking a new agreement with Sweden's Enzymatica.
With FSA set to publish its public register detailing which CBD supplements can lawfully remain on the UK market, what can companies do if their product doesn't make the list? Barrister Jonathan Kirk QC set out the limited options left open to firms during a recent webinar.
The latest European consumer health business news: France's Mayoly Spindler acquires Italian supplements specialist Biohealth; UK-based Flarin gets funding to expand at home and abroad; and Sweden's Karo plots further M&A in 2021.